机构：[1]Department of Oncology, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, People’s Republic of China[2]Central Sterile Supply Department, Integrated Hospital of Traditional Chinese Medicine, Southern Medical University, Guangzhou, Guangdong, People’s Republic of[3]Department of Information, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, People’s Republic of China[4]Guangdong Fusion Application Engineering Center of Medical Big Data, Guangzhou, Guangdong, People’s Republic of China
This project is funded by the College Student Innovation and
Entrepreneurship Training Program (Number：S201912121088,
201912121192, 201912121213, 201912121216). Special Funds for the
Cultivation of Guangdong College Students’ Scientific and Technological Innovation (pdjh2019b0104).
语种：
外文
WOS：
PubmedID：
中科院(CAS)分区：
出版当年[2019]版：
大类|3 区医学
小类|3 区医学：研究与实验3 区药学
最新[2025]版：
大类|2 区医学
小类|2 区医学：研究与实验2 区药学
JCR分区：
出版当年[2018]版：
Q1PHARMACOLOGY & PHARMACYQ2MEDICINE, RESEARCH & EXPERIMENTAL
最新[2023]版：
Q1MEDICINE, RESEARCH & EXPERIMENTALQ1PHARMACOLOGY & PHARMACY
第一作者机构：[1]Department of Oncology, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, People’s Republic of China
共同第一作者：
通讯作者：
通讯机构：[1]Department of Oncology, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, People’s Republic of China[3]Department of Information, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, People’s Republic of China[4]Guangdong Fusion Application Engineering Center of Medical Big Data, Guangzhou, Guangdong, People’s Republic of China[*1]Department of Oncology, Zhujiang Hospital, Southern Medical University, 253 Industry Road, Guangzhou, 510282, People’s Republic[*2]Department of Information, Zhujiang Hospital, Southern Medical University, 253 Industry Road, Guangzhou, 510282, People’s Republic of China.
推荐引用方式(GB/T 7714)：
Lin Weiyin,Lin Anqi,Li Zhefu,et al.Potential predictive value of SCN4A mutation status for immune checkpoint inhibitors in melanoma.[J].BIOMEDICINE & PHARMACOTHERAPY.2020,131:doi:10.1016/j.biopha.2020.110633.
APA：
Lin Weiyin,Lin Anqi,Li Zhefu,Zhou Chaozheng,Chen Chufeng...&Luo Peng.(2020).Potential predictive value of SCN4A mutation status for immune checkpoint inhibitors in melanoma..BIOMEDICINE & PHARMACOTHERAPY,131,
MLA：
Lin Weiyin,et al."Potential predictive value of SCN4A mutation status for immune checkpoint inhibitors in melanoma.".BIOMEDICINE & PHARMACOTHERAPY 131.(2020)
